MONICA LIEU: Open Payments
NPI 1184225377 · SANTA ANA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,466 in 197 payments from 20 companies in 2025. Trend: 2023 $178 · 2024 $71 · 2025 $4,466
Food & beverage: $4,466
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 19 | $610 |
| Otsuka America Pharmaceutical, Inc. | 20 | $490 |
| ABBVIE INC. | 22 | $488 |
| Neurocrine BioSciences, Inc. | 14 | $384 |
| Teva Pharmaceuticals USA, Inc. | 21 | $360 |
| Vanda Pharmaceuticals Inc. | 15 | $329 |
| E.R. Squibb & Sons, L.L.C. | 11 | $316 |
| Alkermes, Inc. | 7 | $252 |
| Axsome Therapeutics, Inc. | 9 | $222 |
| Noven Therapeutics, LLC | 10 | $164 |
Products named: VRAYLAR, SPRAVATO, INGREZZA, REXULTI, FANAPT, COBENFY, AUSTEDO XR, Auvelity.
Industry payments across CA — which companies pay providers there.
